Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

Statement of Comprehensive Income

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Boston Scientific Corp., consolidated statement of comprehensive income

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Net income (loss) 698 1,041 (82) 4,700 1,671
Foreign currency translation adjustment (94) (125) 76 195 (21)
Net change in derivative financial instruments 63 170 (138) 62 110
Net change in defined benefit pensions and other items 37 10 (1) (20) 2
Other comprehensive income (loss), net of tax 6 55 (63) 237 91
Comprehensive income (loss) 704 1,096 (145) 4,937 1,762

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Comprehensive income item Description The company
Net income (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Boston Scientific Corp. net income (loss) increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.
Comprehensive income (loss) Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Boston Scientific Corp. comprehensive income (loss) increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.